Merck (MRK) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Merck (MRK) over the last 16 years, with Q3 2025 value amounting to $3.6 billion.
- Merck's Other Operating Expenses fell 768.25% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 billion, marking a year-over-year decrease of 457.83%. This contributed to the annual value of $15.2 billion for FY2024, which is 857.64% down from last year.
- Latest data reveals that Merck reported Other Operating Expenses of $3.6 billion as of Q3 2025, which was down 768.25% from $3.6 billion recorded in Q2 2025.
- Merck's Other Operating Expenses' 5-year high stood at $6.1 billion during Q1 2022, with a 5-year trough of $2.7 billion in Q1 2021.
- For the 5-year period, Merck's Other Operating Expenses averaged around $3.9 billion, with its median value being $3.8 billion (2022).
- Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 12186.59% in 2022, then plummeted by 3405.06% in 2023.
- Quarter analysis of 5 years shows Merck's Other Operating Expenses stood at $3.5 billion in 2021, then increased by 7.51% to $3.8 billion in 2022, then increased by 4.83% to $4.0 billion in 2023, then decreased by 0.88% to $4.0 billion in 2024, then fell by 8.55% to $3.6 billion in 2025.
- Its last three reported values are $3.6 billion in Q3 2025, $3.6 billion for Q2 2025, and $3.4 billion during Q1 2025.